Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R3 Study of lisinopril versus placebo in HIV-infected adults at risk for kidney complications in Nigeria
PACTR201711002808414Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of lisinopril in human immunodeficiency virus infection (HIV) and chronic kidney disease (CKD) (2 arms), sponsored by Vanderbilt University Medical Center. Started Nov 2017; status: recruiting.
02
Drugs
lisinopril
03
Conditions
human immunodeficiency virus infection (HIV)chronic kidney disease (CKD)
Beyond the preview
Go deeper on PACTR201711002808414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201711002808414.